Try our Advanced Search for more refined results
Health - January, 2011
207 articles
- Spinal Kinetics Denied Quick Win In Implant IP Battle
- Judge Sanctions Roxane In Asacol Patent Suit
- The Persistent Churn Of Law Firm CMOs
- Fla. Judge Strikes Down Health Care Law
- Judge Nixes Bayer Patent Suit Over Centocor's Simponi
- GSK Settles Wrongful Death Suit In Avandia MDL
- Becton Dickinson Faces Patent Suit Over Needles
- Genzyme, Sanofi Make Progress Toward Takeover Deal
- Psychiatric Facility Wants Medicare Fraud Suit Nixed
- Novartis Sues Biogen, Others Over Gene Sequencing IP
- J&J Slammed With $482M Verdict In Stent Patent Suit
- InSight Prepack Plan Gets Green Light
- Newly Bankrupt Angiotech Ends Merger Fight For $6M
- NovaMed Investors Move To Block $214M HIG Merger
- Novartis' Lescol Patent Enforceable, Judge Says
- ReNeuron To Pay Neuralstem To End Stem Cell Row
- Ala. High Court Upholds $3B Scrushy Fraud Verdict
- Health Care In The DOJ's Antitrust Crosshairs
- Fed. Circ. Keeps Tyco Appeal Alive In Restoril Row
- US Sues Guidant Over Defective Defibrillators
- Baxter Hit With FDA Warning Over Puerto Rico Plants
- NY AG's Office Beefs Up Fraud-Fighting Units
- Dutch Court Nixes GSK Asthma Drug Patent
- Ex-Hospital VP Asks For 2 Years In Corruption Case
- FDA Eyes AngioDynamics Over Surgical Knife Marketing
- HGS Sues Genentech To Protect Lupus Drug
- Roche Hit With Suit Over Blood Typing Patent
- Physicist Group Loses Bid To Nix Antitrust Suit
- Wis. Gov. Signs Tort Reform Bill Despite Criticism
- Ex-Pa. Gov. Rendell Returns To Ballard Spahr
- HIPAA's Potential Impact On FMLA Certification
- Warner Chilcott, Roche Sue Teva Over Actonel ANDA
- AstraZeneca To Pay $20.5M In Ky. Medicaid Fraud Suit
- Fed. Circ. Trims Medtronic Surgery Patent Claims
- 4th Circ. Puts Health Care Reform Fight On Fast Track
- Sens. Call For Stiffer Health Care Fraud Penalties
- Pfizer Sanctioned Over Shoddy Witness Testimony
- Judge Grants St. Vincent Ch. 11 Plan Extension
- FDA Suspects Link Between Breast Implants, Cancer
- 8th Circ. OKs Online Research Fees For Attys
- FDA Set To Bump Defibrillators Up In Risk Class
- Dow Jones Seeks To Shine Light On Medicare Database
- Kohl Resurrects 3 Antitrust Bills For New Congress
- Omnicare V. UnitedHealth: Premerger Best Practices
- House Panel Hits Obama On Regulatory Burden
- Ortho Beats Watson Defenses In Birth Control IP Spat
- DOJ Eyes Defibrillators In Medicare Overbilling Probe
- 5th Circ. Affirms Dismissal Of Stryker Prosthetic Suit
- US To Weigh In On Legality Of False Marking Statute
- NY Assembly Committee Advances E-Cigarette Ban
- AGs Ask 8th Circ. To Revive Drug Monopoly Suit
- Mylan Settles Suits Over Pfizer's Lipitor, Caduet
- Mo. V. Spilton And False Claims Penalties
- Sullivan & Cromwell Reps Amgen In $1B BioVex Deal
- Mylan Faces Patent Suit Over Generic Comtan
- Protected Docs Still In Play In Generic Asacol Spat
- US Won $2.5B In Health Care Fraud Cases In '10: Study
- DC Circ. Won't Revisit Decision On E-Cigarettes
- Cravath Advises Novartis In $470M Genoptix Deal
- 7th Circ. OKs US Discovery In German Bone Cement Suit
- Wellness Coach Hits UnitedHealth With FLSA Action
- 9th Circ. Rules On Preemption In Generics Case
- Cialis Patent Suit Won't Go Before Supreme Court
- GAO Downs Protest Over Home Care Contract Terms
- DOJ Ends J&J Blood Reagent Price-Fixing Probe
- Sen. Probes DOD Contracts For Brain Injury Study
- Snake Oil And Search Warrants
- Allergan Investor Suit Over Botox Deal Put On Hold
- Pfizer Silences Testimony On Short-Term Prempro Use
- Reid, Pelosi Back Health Reform In 6th Circ. Battle
- Walgreens Ducks Fraud Action Over Pills In 7th Circ.
- 4th Circ. Nixes Challenge To Stem Cell Funding
- Fresenius Sues Zydus Over Generic PhosLo GelCaps
- St. Jude To Pay $16M To Settle FCA Suit
- Lilly Targets Pharma Cos. In Gemzar ITC Suit
- King Sues Intelliject Over EpiPen Patent Violation
- The Rise Of 3rd-Party Litigation Funding
- Funds Frozen In Seattle Genetics Insider Trading Case
- United, Merck Hit With Navy Communications IP Suits
- Bard Scores Partial Win In Covidien Patent Fight
- Celgene Ordered To Turn Over Thalomid Price Data
- Hospital VP Gets 9 Years In Cleveland Corruption Case
- Pros And Cons Of Cloud Computing
- Pfizer Sued Over Termination Of Wyeth Patent Pact
- Trumpf Wins Refund Of Surgical Lamp Duties
- House Sets Stage For Health Care Replacement
- Morgan Lewis Reps Perrigo In $540M Paddock Labs Buy
- Supreme Court Mulls Medicaid Clinics' Rights To Sue
- FDA Unveils Changes To Medical Device Review Process
- House Deals Symbolic Blow To Health Care Law
- Genetics Co. Sues 6 Labs Over DNA Test Patent
- Who's Afraid Of ACOs?
- 8th Circ. Revives Class Action Over KV Recalls
- Judge Finds Novo's Prandin Patent Invalid
- J&J Unit Recalls 43M Bottles Made In Pa. Plant
- Boston Scientific To Pay Up To $375M For Atritech
- Drug Cos. Try To Keep Cephalon Case Info Under Wraps
- Judge Sets Stage For Trial In Norvir Monopoly Case
- Fla. Asks To Add 6 States To Health Law Fight
- Supreme Court Weighs Class Rules In Baycol Case
- Mylan, Ethypharm Strike Deal In FazaClo Patent Spat
- $76M Mylan Suit Remanded Over Jurisdictional Issues
- GSK To Pay £2.2B Legal Bill For Avandia Suits
- High Court Won't Hear Apotex's Exclusivity Appeal
- DOJ, Health Care Reform Challengers Launch Appeals
- Weil Advises Advent In $1.5B Buy Of Priory From RBS
- Ex-Stryker Exec Tries To Nix Cover-Up Claim
- White House Embarks On Regulatory Overhaul
- High Court To Hear Fight Over Calif. Medicaid Cuts
- Ciba, J&J End Acuvue Patent Row In Fed. Circ.
- Case Study: Matrixx Initiatives Inc. V. Siracusano
- EU Seeks Info On Drug Patent Deals From 2010
- Abbott Scores $16M Win In Suit Over Generic Tarka
- Sanofi Beats Back Apotex Generic In Uroxatral MDL
- SEC Hits Former MediCor CEO With Fraud Suit
- Judge OKs $51M Florida Medicaid Contract
- Bankruptcy Appeals Court Says Qualia Can Avoid Liens
- FDA Urged To Boost Oversight Of Food Safety Claims
- Venable Lures FDA Regulatory Expert To DC Outpost
- Blue Shield Offers Up Calif. Rates For Review
- Watson, Teva Clash Over Seasonique In Fed. Circ.
- High Court To Get Shot At Health Care Antitrust Suit
- Sanofi Heart Drug Multaq Linked To Liver Failure
- CHS Aims To Oust Tenet Board In $3.3B Takeover Bid
- CytoCore Exec Settles Insider Trading Allegations
- The Constitutionality Of Mandated Health Insurance
- Judge OKs $4.75M Quigley Deal Over Asbestos Claims
- Shire Sues Alkem Over Fosrenol Patents
- Ex-Home Diagnostics CEO Charged With Insider Trading
- Bayer Sues Sun Pharmaceutical Over Yaz Patents
- Calif. Insurance Head Wants Rate Increases Delayed
- Trial Patient Sues Abbott Over Humira Cancer Risks
- Aventis Sues Sandoz Over Generic Taxotere
- FTC Will Challenge Consummated Acquisitions
- FDA Limits Acetaminophen Use In Prescription Drugs
- Allergan Sues Sandoz Over Sanctura XR Patents
- Spire Sues Creganna Unit Over Catheter Flaws
- Ore. AG Says Phantom Recall Misled Consumers
- Ad Groups Fired Up Over Graphic Cigarette Labels
- Kansas AG Wants In On Health Care Challenge
- Guidant To Pay $296M Penalty In Defibrillator Case
- Fen-Phen Lawyer Indicted For Insurance Fraud
- TriMed Resolves Stryker Suit Over Wrist Repair IP
- NYC Abused Medicaid Programs, US Atty Claims
- Ex-Mich. AG Joins Dykema's Health Care Practice
- US Chamber Calls For End To 'Regulatory Tsunami'
- Novo Seeks To Toss Antitrust Claims in Prandin Suit
- Aetna Inks Unique $150M Health Reinsurance Deal
- Medical Residents Must Pay Taxes, High Court Rules
- Merck Unit EMD Faces False Patent Marking Suit
- Apotex Sues Forest Labs Over Generic Lexapro
- Sobering Developments In Health Care Exclusion
- Justices Mull Drug Disclosures In Matrixx Fraud Case
- CVS To Pay $1M To Bury Banned Pharmacist Case
- Ex-InterMune CEO Says Withheld Docs Clear His Name
- Ohio To Join 20 States Challenging Health Care Law
- HealthSouth Wins Appeal In Search For Scrushy Assets
- 7th Circ. Upholds Omnicare Antitrust Suit Dismissal
- Boston Scientific Bags $104M IP Arbitration Deal
- Post Ariad: Written Descriptions For Patents
- Divided High Court Won't Hear Commerce Clause Case
- Judge Voids PDL Antibody Patent In MedImmune Suit
- US Backs Drugmakers In Supreme Court Pricing Suit
- AGs Push High Court To Hear Pay-For-Delay Drug Suit
- Amgen Wins Ban On Teva's Generic Version Of Sensipar
- HHS, EPA Address Current Water Fluoridation Levels
- FDA Aims To Bolster Industry Transparency
- Aurobindo, Wyeth Settle Fight Over Generic Effexor
- Judge Stands By $21M Jury Verdict In Sulindac Case
- Lilly, Xanodyne Hid Darvocet Risks, Suit Says
- Sanofi Targets Accord Over Generic Taxotere
- Navinta Faces New Suit Over Generic Naropin ANDA
- AAI Asks 8th Circ. To Revive FTC Drug Monopoly Suit
- House Advances Health Care Repeal Vote
- What Did You Know, When Did You Know It?
- FDA Doesn't Have To Release Provenge Docs: 2nd Circ.
- ProMedica's Hospital Buy Hurts Competition, FTC Says
- The Clock Is Ticking On GME Funding Applications
- Judge Shuts Door On Medtronic ERISA Action
- Mich. Can Fight Class Cert. In ERISA Suit: 6th Circ.
- Baker Hostetler Reps Texas Health In MedicalEdge Buy
- La. To Shell Out $240M For Medicaid Overpayments
- Shareholders Join Suits In XenoPort Stock Price Case
- Get It In Writing Or Pay The Consequences
- HHS Warns Of Health Care Repeal Dangers
- Nycomed Calls On WilmerHale In Vanos Patent Suit
- Novartis Loses Bid To Toss $2.6M Zometa Award
- GSK Loses Bid To Bar Testimony On Avandia Risks
- 2nd Circ. Spares UBS From $40M Arbitration Claim
- Fed. Circ. Remands Prosthetics Patent Suit
- FDA Tackles Food Safety As Funding Remains Uncertain
- Judge OKs $15M DIP Package In InSight Ch. 11
- Portuguese Court Upholds €3M Abbott Price-Fixing Fine
- False Marking Suit Survives Ranbaxy's Dismissal Bid
- Employers' Genetic Information Obligations
- FDA Deputy Commissioner To Resign For Md. Job
- Fresenius To Pay €485M For Euromedic Dialysis Unit
- Huron, Empire Can't Shake St. Vincent False Claims Suit
- Wis. Joins Fight Against Health Care Reform
- PharmAthene, SIGA Fight Over Bioterror Defense Drug
- Detroit Medical Center Fined $30M For Illegal Perks
- Mylan To Pay $65M To Bury Medicaid Inflation Claims
- Paul Weiss Reps Universal In $1.25B CVS Deal
- FTC Challenges Lundbeck Drug Monopoly In 8th Circ.
- Latency Periods And The Statute Of Limitations
- Lupin Strikes Deal In Suit Over Generic Lunesta
- Wyeth Hit With $1.5M Verdict In Prempro Case